The first Sage Therapeutics trade was made in Q3 2022.
Since then Ken Fisher bought shares four more times and sold shares on five occasions. The investor completely sold their stake between Q3 2024 and Q4 2024.
Avg closing price
Price range
Sold -433 Thousand shares
Q4 2024
Avg closing price
$6.10
Price range
$4.78
-
$8.54
Sold 0.9% shares (-3.88 Thousand shares)
Q3 2024
Avg closing price
$9.17
Price range
$7.02
-
$13.08
Increased shares by 0.9% (+3.95 Thousand shares)
Q2 2024
Avg closing price
$12.81
Price range
$10.58
-
$17.90
Increased shares by 0.1% (+544 shares)
Q1 2024
Avg closing price
$23.07
Price range
$18.62
-
$26.95
Increased shares by 8.1% (+32.3 Thousand shares)
Q4 2023
Avg closing price
$19.82
Price range
$17.10
-
$22.26
Sold 7.3% shares (-31.5 Thousand shares)
Q3 2023
Avg closing price
$28.88
Price range
$16.75
-
$48.98
Increased shares by 2.4% (+10.2 Thousand shares)
Q2 2023